Lack of association between the SOST gene and bone mineral density in perimenopausal women: Analysis of five polymorphisms

Bone

Volumn 31, Issue 4, 2002, Pages 515-519

  Balemans, W ^a   Foernzler, D ^b   Parsons, C ^c   Ebeling, M ^d   Thompson, A ^b   Reid, D M ^c   Lindpaintner, K ^b   Ralston, S H ^c   Van hul, W ^a,e  

^a ANTWERP UNIVERSITY HOSPITAL   (Belgium)

^b F HOFFMANN LA ROCHE LTD   (Switzerland)

^c UNIVERSITY OF ABERDEEN   (United Kingdom)

^d F HOFFMANN LA ROCHE LTD   (Switzerland)

^e UNIVERSITY OF ANTWERP   (Belgium)

Author keywords

Association study; Bone mineral density (BMD); Osteoporosis; Polymorphisms; SOST

Indexed keywords

GENOMIC DNA; BONE MORPHOGENETIC PROTEIN; PROTEIN; SOST PROTEIN, HUMAN;

ADULT; ARTICLE; BONE DENSITY; BONE DYSPLASIA; BONE MINERAL; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; POSTMENOPAUSE OSTEOPOROSIS; CLIMACTERIUM; GENETIC MARKER; GENETIC POLYMORPHISM; GENETICS; MIDDLE AGED;

BONE DENSITY; BONE MORPHOGENETIC PROTEINS; CLIMACTERIC; FEMALE; GENETIC MARKERS; HUMANS; MIDDLE AGED; POLYMORPHISM, GENETIC; PROTEINS;

EID: 0036795988     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/S8756-3282(02)00844-X     Document Type: Article

References (39)

1. Risk factor for postmenopausal osteoporosis
2. Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST)
3. Sclerosteosis
4. Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein
5. A novel polymorphism in the promoter region for the human osteocalcin gene; The possibility of a correlation with bone mineral density in postmenopausal Japanese women
6. Suggestive linkage of the parathyroid receptor type 1 to osteoporosis
7. Vitamin D receptor gene start codon polymorphisms (FokI) and bone mineral density; Interaction with age, dietary calcium, and 3′-end region polymorphisms
8. Defects in TC1RG1 subunit of the vacuolar proton pump are responsible for a subset of human autosomal recessive osteopetrosis
9. Recruitment techniques for screening programmes; Trial of a new method within a regional osteoporosis study
10. The Osteoporosis-Pseudoglioma Syndrome Collaborative Group. LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development
11. Reduced bone density and osteoporosis associated with a polymorphic Sp1 site in the collagen type I alpha I gene
12. Role of peak bone mass and bone loss in postmenopausal osteoporosis; 12 year study
13. Nutritional factors in osteoporosis
14. Association study of parathyroid hormone gene polymorphism and bone mineral density in Japanese postmenopausal women
15. Mutations in the gene encoding the latency-associated peptide of TGF-beta 1 cause Camurati-Engelmann disease
16. The diagnosis of osteoporosis
17. Evidence of association and linkage disequilibrium between a novel polymorphism in the transforming growth factor beta 1 gene and hip bone mineral density; A study of female twins
18. Genetic regulation of peak bone mass
19. Domain specific mutations in TGFB1 result in Camurati-Engelmann disease
20. Quantitative trait loci affecting bone mineral density
21. Association of bone mineral density with polymorphisms of the estrogen receptor gene in post-menopausal women
22. Linkage of a QTL contributing to normal variation in bone mineral density to chromosome 11q12-13
23. Genetic dissection of complex traits
24. A sequence variation 713-8 delC in the transforming growth factor-beta 1 gene has higher prevalence in osteoporotic women than in normal women and is associated with very low bone mass in osteoporotic women and increased bone turnover in both osteoporotic and normal women
25. A semi-automated system for analysis and storage of SNPs
26. A mutation in the LDL receptor-related protein 5 gene results in the autosomal dominant high-bone-mass trait
27. Polymorphisms of the calcitonin receptor gene are associated with bone mineral density in postmenopausal Italian women
28. Contribution of trans-acting factor alleles to normal physiological variability; Vitamin D receptor gene polymorphisms and circulating osteocalcin
29. Prediction of bone density from vitamin D receptor alleles
30. Polymorphisms of the interleukin-6 gene are associated with bone mineral density
31. Genetic determinants of bone mass in adults. A twin study
32. Association of estrogen receptor dinucleotide repeat polymorphism with osteoporosis
33. Identification of peak bone mass QTL in a spontaneously osteoporotic mouse strain
34. The mutational spectrum of human malignant autosomal recessive osteopetrosis
35. Influence of vitamin D receptor genotype on bone mineral density in postmenopausal women; A twin study in Britain
36. Role of genetic factors in the pathogenesis of osteoporosis
37. Calcitonin receptor polymorphism is associated with a decreased fracture risk in post-menopausal women
38. Recruitment methods for screening programmes. II; Trial of an improved method within a regional osteoporosis study
39. Association of a polymorphism of the transforming growth factor-beta 1 gene with genetic susceptibility to osteoporosis in postmenopausal Japanese women